Ajit Rao, MD
Vascular Surgery · New York, NYNPI 1952729956
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.8%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Medtronic at 31.4% of the total. 2025 is the largest year on record at $157,073, more than ten times the $777 reported in 2019. Among vascular surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 824 payments — averaging $356.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$92K
- W. L. Gore & Associates, Inc.$59K
- Abbott$51K
- Bard Peripheral Vascular, Inc.$27K
- Penumbra, Inc.$22K
- Endologix LLC$20K
- plus $23K from 22 others
Across 7 payments — averaging $5064.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$35K
What the payments were for
- Consulting fees$140,44048%
- Speaking & faculty fees$90,22031%
- Travel & lodging$24,9388%
- Food & beverage$38,11813%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 471 | $92,163 |
| W. L. Gore & Associates, Inc. | 84 | $59,056 |
| Abbott | 47 | $51,215 |
| Bard Peripheral Vascular, Inc. | 17 | $27,271 |
| Penumbra, Inc. | 51 | $21,519 |
| Endologix LLC | 47 | $19,670 |
| Stryker | 13 | $12,932 |
| Inari Medical, Inc. | 6 | $4,309 |
| Cook Medical LLC | 25 | $1,148 |
| Shockwave Medical, Inc | 11 | $1,047 |
| Bolton Medical Inc | 8 | $974 |
| Philips North America LLC | 6 | $707 |
| Viz.ai, Inc. | 2 | $393 |
| Tactile Systems Technology Inc | 10 | $280 |
| Artivion, Inc. | 3 | $218 |
| Vasorum USA Inc. | 1 | $178 |
| Silk Road Medical, Inc. | 6 | $167 |
| Boston Scientific | 3 | $79 |
| Axogen | 1 | $76 |
| Lemaitre Vascular, Inc. | 3 | $65 |
| Integra Lifesciences Corporation | 1 | $52 |
| Kerecis Limited | 1 | $32 |
| Advanced Oxygen Therapy Inc. | 1 | $30 |
| Cardiovascular Systems Inc. | 2 | $30 |
| Humacyte Global, Inc. | 1 | $28 |
| Solventum Corporation | 1 | $27 |
| Argon Medical Devices, Inc. | 1 | $26 |
| Smith+Nephew | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HawkOne$64,740
- GORE VIABAHN VBX Balloon Expandable Endo$54,009
- GORE VIABAHN Endoprosthesis with Heparin$44,599
- VIABAHN Endoprosthesis with PROPATEN Bioactive Surface$23,655
- ESPRIT$21,874
- Indigo System$19,137
- Perclose ProStyle$18,150
- Torus Stent Graft System$14,888
- ENDOCROSS Device$14,708
- CT THROMBECTOMY SYSTEM KIT$12,693
- FLOWTRIEVER CATHETER, S$11,693
- PERCLOSE PROGLIDE$7,657
- LIMFLOW SYSTEM$4,161
- GORE EXCLUDER Iliac Branch Endoprosthesis$2,720
- TurboHawk$2,260
- AFX2 Bifurcated Endograft System$2,100
- Alto Abdominal Stent Graft System$1,876
- COROFLOW$1,562
- Product in Development$1,360
- Penumbra System$803
How this compares
$293,716 in reported general payments places this provider in the 95th percentile of 405 vascular surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 29 | $191 |
| ClopidogrelClopidogrel Bisulfate | 20 | $189 |
| Oxycodone Hcl | 29 | $38 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in New York
- Gary GelbfishNew York$1.9M
- John LantisNew York$922K
- Brian DerubertisNew York$714K
- James McKinseyNew York$616K
- Peter FariesNew York$494K
- Daniel HanNew York$280K
- Todd BerlandNew York$260K
- Thomas MaldonadoNew York$249K
- Karan GargNew York$246K
- Rami TadrosNew York$218K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.